MetaCap

DBV Technologies S.A. Insider Trades

NASDAQ: DBVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

9.02-0.40 (-4.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
5 · $15.49M
Shares bought / sold
0 / 3.37M
Net activity
Net selling $15.5 million

DBV Technologies S.A. insider activity

Over the last 12 months, DBV Technologies S.A. insiders reported 5 transactions on SEC Form 4: 0 open-market purchases and 5 sales. Insiders bought $0 and sold $15.5 million worth of stock, for net insider selling of $15.5 million. The largest seller was EPIC Bpifrance & Bpifrance Participations SA & Bpifrance SA & Bpifrance Investissement S.A.S. & CAISSE DES DEPOTS ET CONSIGNATIONS, with $15.5 million in reported sales.

The most recent filing shows Mohideen Pharis (Chief Medical Officer) selling 464 shares at $2.70 on Jul 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DBVT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

DBVT insider transactions

DBV Technologies S.A. insider transactions
DateInsiderTypeSharesValueFiling
Jul 29, 2026Mohideen PharisChief Medical OfficerSale464$1.25KForm 4
Jan 29, 2026Mohideen PharisChief Medical OfficerSale534$2.60KForm 4
Dec 18, 2025EPIC Bpifrance & Bpifrance Participations SA & Bpifrance SA & Bpifrance Investissement S.A.S. & CAISSE DES DEPOTS ET CONSIGNATIONSMember of 10% owner groupSale1,292,103$5.41MForm 4
Dec 17, 2025EPIC Bpifrance & Bpifrance Participations SA & Bpifrance SA & Bpifrance Investissement S.A.S. & CAISSE DES DEPOTS ET CONSIGNATIONSMember of 10% owner groupSale40,000$211.20KForm 4
Dec 17, 2025EPIC Bpifrance & Bpifrance Participations SA & Bpifrance SA & Bpifrance Investissement S.A.S. & CAISSE DES DEPOTS ET CONSIGNATIONSMember of 10% owner groupSale2,036,990$9.86MForm 4
Nov 21, 2025Trapp Kevin MichaelChief Commercial OfficerAward55,000—Form 4
Nov 21, 2025Boucinha VirginieChief Financial OfficerAward32,000—Form 4
Nov 21, 2025Mohideen PharisChief Medical OfficerAward44,000—Form 4
Nov 21, 2025Mohideen PharisChief Medical OfficerSale1,624$4.50KForm 4
Nov 20, 2025Mohideen PharisChief Medical OfficerSale6,496$18.71KForm 4
Jul 29, 2025Mohideen PharisChief Medical OfficerSale464$1.03KForm 4
May 22, 2025Mohideen PharisChief Medical OfficerSale397$730.48Form 4
Jan 30, 2025Mohideen PharisChief Medical OfficerSale600$510Form 4
Nov 25, 2024Mohideen PharisChief Medical OfficerSale565$322.05Form 4
Nov 22, 2024Mohideen PharisChief Medical OfficerSale342$181.26Form 4
Nov 21, 2024Mohideen PharisChief Medical OfficerSale2,350$1.27KForm 4
Nov 21, 2024Mohideen PharisChief Medical OfficerAward35,000—Form 4
Nov 21, 2024Boucinha VirginieChief Financial OfficerAward19,000—Form 4
Jul 29, 2024Mohideen PharisChief Medical OfficerSale1,785$1.75KForm 4
May 24, 2024Mohideen PharisChief Medical OfficerSale660$897.60Form 4
May 22, 2024Mohideen PharisChief Medical OfficerSale382$527.16Form 4
Mar 8, 2024Tasse DanielCHIEF EXECUTIVE OFFICERBuy17,094$14.19KForm 4
Feb 6, 2024Ndu AdoraDirectorBuy1,825$1.62KForm 4
Nov 22, 2023Mohideen PharisChief Medical OfficerSale2,245$3.91KForm 4
Nov 20, 2023Mohideen PharisChief Medical OfficerAward35,000—Form 4
Nov 20, 2023Boucinha VirginieChief Financial OfficerAward19,000—Form 4
Aug 25, 2023MORRIS TIMOTHY EDirectorBuy12,000$18.24KForm 4
Aug 1, 2023SOLAND DANIEL BDirectorBuy15,000$24.30KForm 4
May 24, 2023Mohideen PharisChief Medical OfficerSale469$1.66KForm 4
Nov 24, 2022Mohideen PharisChief Medical OfficerSale1,792$5.16KForm 4
Nov 21, 2022Robitaille SebastienChief Financial OfficerAward8,000—Form 4
Nov 21, 2022Mohideen PharisChief Medical OfficerAward17,500—Form 4
Jul 29, 2022Mohideen PharisChief Medical OfficerAward10,000—Form 4
Jun 13, 2022BAKER BROS. ADVISORS LP & 667, L.P. & BAKER JULIAN & BAKER FELIX & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LPDirectorAward10,622,568—Form 4
Jun 13, 2022BAKER BROS. ADVISORS LP & 667, L.P. & BAKER JULIAN & BAKER FELIX & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LPDirectorAward1,252,432—Form 4
Nov 22, 2021Robitaille SebastienChief Financial OfficerAward5,000—Form 4
Nov 22, 2021Mohideen PharisChief Medical OfficerAward8,700—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related